A late-stage North American trial of Avigan in patients with mild to moderate COVID-19 will continue, the Indian drugmaker said on Wednesday in a regulatory filing.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ceLUHP
via IFTTT
Dr.Reddy's terminates COVID-19 treatment study in Kuwait
A late-stage North American trial of Avigan in patients with mild to moderate COVID-19 will continue, the Indian drugmaker said on Wednesday in a regulatory filing.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ceLUHP
via IFTTT
No comments:
Post a Comment